Nuclear expression of lysyl oxidase enzyme is an independent prognostic factor in rectal cancer patients
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Nuclear expression of lysyl oxidase enzyme is an independent prognostic factor in rectal cancer patients. / Liu, Na; Cox, Thomas R; Cui, Weiyingqi; Adell, Gunnar; Holmlund, Birgitta; Ping, Jie; Jarlsfelt, Ingvar; Erler, Janine T; Sun, Xiao-Feng.
In: OncoTarget, Vol. 8, No. 36, 01.09.2017, p. 60015-60024.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Nuclear expression of lysyl oxidase enzyme is an independent prognostic factor in rectal cancer patients
AU - Liu, Na
AU - Cox, Thomas R
AU - Cui, Weiyingqi
AU - Adell, Gunnar
AU - Holmlund, Birgitta
AU - Ping, Jie
AU - Jarlsfelt, Ingvar
AU - Erler, Janine T
AU - Sun, Xiao-Feng
PY - 2017/9/1
Y1 - 2017/9/1
N2 - Emerging evidence has implicated a pivotal role for lysyl oxidase (LOX) in cancer progression and metastasis. Whilst the majority of work has focused on the extracellular matrix cross-linking role of LOX, the exact function of intracellular LOX localisation remains unclear. In this study, we analysed the LOX expression patterns in the nuclei of rectal cancer patient samples and determined the clinical significance of this expression. Nuclear LOX expression was significantly increased in patient lymph node metastases compared to their primary tumours. High nuclear LOX expression in tumours was correlated with a high rate of distant metastasis and increased recurrence. Multivariable analysis showed that high nuclear LOX expression was also correlated with poor overall survival and disease free survival. Furthermore, we are the first to identify LOX enzyme isoforms (50 kDa and 32 kDa) within the nucleus of colon cancer cell lines by confocal microscopy and Western blot. Our results show a powerful link between nuclear LOX expression in tumours and patient survival, and offer a promising prognostic biomarker for rectal cancer patients.
AB - Emerging evidence has implicated a pivotal role for lysyl oxidase (LOX) in cancer progression and metastasis. Whilst the majority of work has focused on the extracellular matrix cross-linking role of LOX, the exact function of intracellular LOX localisation remains unclear. In this study, we analysed the LOX expression patterns in the nuclei of rectal cancer patient samples and determined the clinical significance of this expression. Nuclear LOX expression was significantly increased in patient lymph node metastases compared to their primary tumours. High nuclear LOX expression in tumours was correlated with a high rate of distant metastasis and increased recurrence. Multivariable analysis showed that high nuclear LOX expression was also correlated with poor overall survival and disease free survival. Furthermore, we are the first to identify LOX enzyme isoforms (50 kDa and 32 kDa) within the nucleus of colon cancer cell lines by confocal microscopy and Western blot. Our results show a powerful link between nuclear LOX expression in tumours and patient survival, and offer a promising prognostic biomarker for rectal cancer patients.
U2 - 10.18632/oncotarget.9623
DO - 10.18632/oncotarget.9623
M3 - Journal article
C2 - 28947950
VL - 8
SP - 60015
EP - 60024
JO - Oncotarget
JF - Oncotarget
SN - 1949-2553
IS - 36
ER -
ID: 165803467